Anesthetics may modulate cancer surgical outcome: a possible role of miRNAs regulation

• Main Authors: Masashi Ishikawa, Masae Iwasaki, Atsuhiro Sakamoto, Daqing Ma
• Format: Article
• Language: English
• Published: BMC 2021-03-01
• Series: BMC Anesthesiology
• Subjects: MicroRNA; Anesthetics; Cancer; Anti-cancer immunity; Cell-to-cell communication
• Online Access: https://doi.org/10.1186/s12871-021-01294-w

Abstract Background microRNAs (miRNAs) are single-stranded and noncoding RNA molecules that control post-transcriptional gene regulation. miRNAs can be tumor suppressors or oncogenes through various mechanism including cancer cell biology, cell-to-cell communication, and anti-cancer immunity. Main Body Anesthetics can affect cell biology through miRNA-mediated regulation of messenger RNA (mRNA). Indeed, sevoflurane was reported to upregulate miR-203 and suppresses breast cancer cell proliferation. Propofol reduces matrix metalloproteinase expression through its impact on miRNAs, leading to anti-cancer microenvironmental changes. Propofol also modifies miRNA expression profile in circulating extracellular vesicles with their subsequent anti-cancer effects via modulating cell-to-cell communication. Conclusion Inhalational and intravenous anesthetics can alter cancer cell biology through various cellular signaling pathways induced by miRNAs’ modification. However, this area of research is insufficient and further study is needed to figure out optimal anesthesia regimens for cancer patients.